Cite
HARVARD Citation
von Kutzleben, S. et al. (2017). Depletion of CD52‐positive cells inhibits the development of central nervous system autoimmune disease, but deletes an immune‐tolerance promoting CD8 T‐cell population. Implications for secondary autoimmunity of alemtuzumab in multiple sclerosis. Immunology. 150 (4), pp. 444-455. [Online].